Brian Kiel
Foot Surgery · Memphis, TNNPI 1316931272
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 17 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Biotissue Holdings Inc. at 25.9% of the total. That places this record below the midpoint for foot surgery clinicians in TN, where the typical reported total is $1,166.
Across 17 payments — averaging $41.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biotissue Holdings Inc.$181
- Stryker$170
- Reprise Biomedical, Inc.$138
- Tenex Health Inc.$59
- Amgen$53
- Smith+Nephew$40
- plus $57 from 3 others
What the payments were for
- Food & beverage$697100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biotissue Holdings Inc. | 2 | $181 |
| Stryker(2 entities) | 3 | $170 |
| Reprise Biomedical, Inc. | 2 | $138 |
| Tenex Health Inc. | 1 | $59 |
| Amgen | 3 | $53 |
| Smith+Nephew | 2 | $40 |
| GRT US Holding, Inc. | 2 | $27 |
| Nevro Corp. | 1 | $16 |
| Nabriva Therapeutics, PLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEOX$141
- CLARIX$141
- MIRO3D$126
- MIS Instrumentation$105
How this compares
$697 in reported general payments places this provider in the 35th percentile of 23 foot surgery providers in Tennessee.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 92 | $1,067 |
| Colchicine | 15 | $780 |
| Gabapentin | 130 | $646 |
| Silver Sulfadiazine | 141 | $588 |
| Doxycycline Hyclate | 26 | $249 |
| SsdSilver Sulfadiazine | 35 | $241 |
| Mupirocin | 18 | $219 |
| Ketoconazole | 12 | $191 |
| Methylprednisolone | 22 | $165 |
| Hydrocortisone | 35 | $140 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 12 | $91 |
| Allopurinol | 14 | $43 |
| Promethazine Hcl | 12 | $36 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Memphis
- David MoinesterMemphis$2K
- Brian ShwerMemphis$2K
- Christopher JuelsCookeville$208K
- Joseph CreazzoMorristown$12K
- David VelardeKnoxville$11K
- David FranklinAlcoa$8K
- Carol AkermanKnoxville$6K
- Mark WrightMurfreesboro$5K
- James EngblomOak Ridge$2K
- Brian ChristiansenOak Ridge$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.